ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 27 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $21,000 | +31.2% | 20,000 | 0.0% | 0.00% | – |
| Q4 2017 | $16,000 | -50.0% | 20,000 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $32,000 | +3.2% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $31,000 | -29.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $44,000 | +131.6% | 20,000 | +100.0% | 0.00% | 0.0% |
| Q4 2016 | $19,000 | -32.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $28,000 | +64.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $17,000 | +466.7% | 10,000 | 0.0% | 0.00% | – |
| Q1 2016 | $3,000 | -90.0% | 10,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $30,000 | +25.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $24,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,907,008 | $21,244,000 | 14.99% |
| Third Rock Ventures, LLC | 4,841,591 | $53,935,000 | 6.29% |
| Broadfin Capital, LLC | 857,715 | $9,555,000 | 1.00% |
| NJ State Employees Deferred Compensation Plan | 25,000 | $278,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 112,485 | $1,253,000 | 0.05% |
| C WorldWide Group Holding A/S | 100,000 | $1,161,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 9,921 | $111,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 19,997 | $223,000 | 0.01% |
| Ground Swell Capital, LLC | 402 | $4,000 | 0.01% |
| Point72 Asset Management, L.P. | 55,450 | $618,000 | 0.01% |